wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34628781-8A26CA34-8FF6-4AD6-9A2C-A5F3001E908D
Q34628781-8A26CA34-8FF6-4AD6-9A2C-A5F3001E908D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34628781-8A26CA34-8FF6-4AD6-9A2C-A5F3001E908D
Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk.
P2860
Q34628781-8A26CA34-8FF6-4AD6-9A2C-A5F3001E908D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34628781-8A26CA34-8FF6-4AD6-9A2C-A5F3001E908D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
941e5de0d7edb0f95e0de47a7e999887a384dec4
P2860
Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes